Concepedia

Jeffrey T. Ha

JT

Statistics

Publications

3

Citations

239

H-Index

3

Active since

2022

Affiliations

The University of Sydney(Current)

UNSW Sydney

The George Institute for Global Health

Libin Cardiovascular Institute of Alberta

University of Manitoba

Jeffrey T. Ha is an author at The University of Sydney specializing in autoimmune kidney disease, iga nephropathy therapy, and nephrology.

ORCID

Publications per year

2022–2023

3

Publications

3

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 215 citations · Full text

, , +12

Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study

Min Jun, Anish Scaria, Jason G. Andrade et al. · European Heart Journal - Quality of Care and Clinical Outcomes · 2022 · 13 citations

, , +14

Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada

Jeffrey T. Ha, Anish Scaria, Jason G. Andrade et al. · Kidney Medicine · 2023 · 11 citations · Full text

, , +17

1–3 of 3